Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GP.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GP.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GP.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GP.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GP.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
HL.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HL.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HL.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HL.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HL.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCDEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XCDEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCDECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XCDECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCDEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XCDEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCDENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCDENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCT.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XCT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCT.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCT.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCT.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XCT.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCT.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.15EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.15ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.15ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.15EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GS.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GS.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GS.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GS.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GS.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used